OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

H. C. Diener, D. W. Dodick, S. K. Aurora, C. C. Turkel, R. E. Degryse, R. B. Lipton, S. D. Silberstein, M. F. Brin

Research output: Contribution to journalArticle

517 Scopus citations

Fingerprint Dive into the research topics of 'OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences